17.05.2016 • News

Albemarle Mulls Sale of Chemetall

US specialty chemicals company Albemarle is exploring the sale of its Chemetall surface-treatment division, according to the news agency Bloomberg. People familiar with the matter told the news agency CEO Luke Kissam is looking for ways to help pay down debt from its $6.2 billion acquisition of Rockwood Holdings in 2014.

Bank of America reportedly has been hired to advise on strategic options for Chemetall, which provides surface-treatment chemicals for metals and plastics and is believed to be worth as much as $3 billion.

Albemarle sold two other businesses earlier this year – minerals and metal sulphides – but abandoned the sale of a a third operation supplying fine chemicals as it did not receive high enough bids.

Chemetall, which was part of the Rockwood deal, reported EBITDA of $52.5 million in the first quarter of 2016, up 14% year on year.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read